Skip to main content
News_

Early career female researchers shine in cancer fellowships

17 February 2017
Sydney researchers receive $6.4M for new and improved cancer treatments

Sydney researchers have received more than $6.4M to develop personalised treatments for ovarian cancer, investigate the link between sleep apnoea and tumour growth and improve the speed, accuracy and thoroughness of cancer diagnosis and treatment decision-making.

NSW Minister for Health and Medical Research, Brad Hazzard, announced the Cancer Institute NSW grants this week, with Sydney researchers receiving the most grants out of any institution.

Six University of Sydney researchers, five of which are female, received Early Career Fellowships and renowned oncologist Professor Roger Reddel, Director of the Children's Medical Research Institute at Westmead, was the only researcher awarded a Translational Program Grant.

He received $3.75M for his work at the ACRF International Centre for the Proteome of Human Cancer (ProCan™), part of the Cancer Moonshot Initiative external from 47th Vice President of the United States, Joe Biden.

Deputy-Vice Chancellor (Research) Professor Duncan Ivison said the grants not only highlighted Sydney’s strength in cancer research, but the extraordinary talent of our early career researchers.

“Our researchers have received half of the Early Career Fellowships awarded in this round.

“This is an outstanding result and we are proud of our talented researchers and their passionate commitment to finding new, safer and more personalised treatments for leukaemia, lung and ovarian cancer.”


Translational Program Grant

  • Professor Roger Reddel - $3.75M (Administered by Children’s Medical Research Institute)
    Transforming protein quantitation technology to improve cancer diagnosis and treatment decisions.

Early Career Fellowships

  • Dr Chun-Chien Shieh - $389,500
    Real-time In-vivo imaging during lung cancer radiotherapy
  • Dr Emily Colvin - $150,000
    Evaluation of lysyl oxidase inhibitors as a new treatment for ovarian cancer
  • Dr Holly Bolton - $576,000
    Improving leukaemia therapy through prevention of graft-versus-host disease
  • Dr Megan Best - $564,500
    Overcoming psychosocial and ethical issues in cancer genomics: Translating test results into behavioural change
  • Dr Kristina Cook - $597,000 (pictured above)
    Losing sleep over cancer: Regulation of HIF–to1 in sleep apnoea and tumour development
  • Dr Maiken Lise Marcker Espersen - $416,500
    Clinical proteomics and personalised treatment in ovarian cancer.